• PND131 - PATIENT PREFERENCES FOR DIFFERENT MODES AND FREQUENCY OF ADMINISTRATION OF MULTIPLE SCLEROSIS DISEASE MODIFYING THERAPIES

    Oct 1, 2018, 00:00

  • PSS35 - SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF PSORIASIS- A 52-WEEK COST PER RESPONDER ANALYSIS FROM THE PORTUGUESE PAYER PERSPECTIVE

    Oct 1, 2018, 00:00

  • PCN137 - THE ECONOMIC EVALUATION OF IMATINIB COMBINED WITH CHEMOTHERAPY FOR PEDIATRIC PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA

    Oct 1, 2018, 00:00

  • PND27 - COST IMPLICATIONS IN THE SELECTION OF FIRST LINE TREATMENT FOR HIGHLY ACTIVE RELAPSING MULTIPLE SCLEROSIS IN PORTUGAL

    Oct 1, 2018, 00:00

  • PIN8 - COMPARATIVE EFFICACY OF FIDAXOMICIN, VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PIN85 - TENOFOVIR ALAFENAMIDE’S IMPACT ON COMORBIDITIES AMONG PEOPLE LIVING WITH HIV IN PORTUGAL- A SIMULATION STUDY

    Oct 1, 2018, 00:00

  • PCV121 - PERFORMANCE INDICATORS OF CARDIAC REHABILITATION IN HUNGARY

    Oct 1, 2018, 00:00

  • PRM67 - UTILITIES IN ONCOLOGY SUBMISSIONS SUBMITTED TO NICE —APPROACH OF THE MANUFACTURERS

    Oct 1, 2018, 00:00

  • PSY149 - IQVIA PATIENT DATA ASSESSMENT- REAL WORLD EVIDENCE IN THE MANAGEMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS

    Oct 1, 2018, 00:00

  • PCP11 - ORGANISATIONAL MODELS AND OPPORTUNITIES FOR EFFICIENCY MEASURING IN HEALTH CARE

    Oct 1, 2018, 00:00

  • PIH40 - THE HEALTH LITERACY OF IRANIAN PARENTS- A SURVEY IN TEHRAN CAPITAL CITY

    Oct 1, 2018, 00:00

  • PDB1 - ACUTE RENAL OUTCOMES WITH SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS- REAL WORLD DATA ANALYSIS

    Oct 1, 2018, 00:00

  • PMD61 - COST EFFECTIVENESS OF DERMABOND PRINEO SKIN CLOSURE SYSTEM IN HIP AND KNEE ARTHROPLASTY IN TURKEY

    Oct 1, 2018, 00:00

  • PIN38 - CLINICAL AND ECONOMIC IMPACT OF THE TREATMENT OF CHRONIC HEPATITIS C IN PRISON INMATES IN SPAIN

    Oct 1, 2018, 00:00

  • PMS69 - BIOSIMILAR AND ORIGINATOR INFLIXIMAB- INFLUENCE OF LOCAL POLICY MEASURES AND PRACTICES ON MARKET DYNAMICS BETWEEN SWEDISH COUNTIES

    Oct 1, 2018, 00:00

  • PND133 - LIVING WITH MIGRAINE- THE IMPACT ON BRAZILIAN PATIENTS LIVES FROM MY MIGRAINE VOICE SURVEY

    Oct 1, 2018, 00:00

  • PHP100 - UTILIZATIONS AND EXPENDITURES OF TUMOR NECROSIS FACTOR ANTAGONISTS IN MEDICARE PART D- CROSS- SECTIONAL STUDY (2014-2015)

    Oct 1, 2018, 00:00

  • PHP12 - PATIENTS’ RELATED ISSUES ARISING FROM TARGET PRODUCT PROFILE, PRODUCT DEVELOPMENT PLAN AND IN THE DESIGN OF CLINICAL TRIALS

    Oct 1, 2018, 00:00

  • PDB32 - SEX- AND SITE-SPECIFIC DIFFERENCES IN COLORECTAL CANCER RISK AMONG PEOPLE WITH TYPE 2 DIABETES

    Oct 1, 2018, 00:00

  • PDB75 - COST-EFFECTIVENESS OF TREATING PATIENTS WITH TYPE 2 DIABETES POORLY CONTROLLED ON BASAL INSULIN WITH FIXED-RATIO COMBINATIONS OF BASAL INSULIN AND GLP-1 RECEPTOR AGONISTS IN DENMARK- IDEGLIRA VERSUS IGLARLIXI

    Oct 1, 2018, 00:00

  • PHP116 - TREND IN OPIOID USE FROM 2001 THROUGH 2013 AMONG ELDERLY US VETERANS

    Oct 1, 2018, 00:00

  • PHP274 - ITALY’S NEW PHARMACEUTICAL INNOVATION RANKING SYSTEM- KEY CRITERIA FOR SUCCESSFULLY ACHIEVING INNOVATIVE STATUS

    Oct 1, 2018, 00:00

  • PCN155 - COST-EFFECTIVENESS OF CPX-351 VERSUS 3+7 AMONG PATIENTS 60 YEARS OF AGE IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) IN THE UNITED KINGDOM (UK)

    Oct 1, 2018, 00:00

  • PIN118 - KNOWLEDGE, ATTITUDE AND PRACTICES ABOUT ZIKA VIRUS AMONG PHARMACY STUDENTS IN THE UNITED STATES (US) AND INDIA- A CROSS SECTIONAL STUDY

    Oct 1, 2018, 00:00

  • PRM77 - VALIDATION OF COPD ICD10 DIAGNOSTIC CODES IN THE SIDIAP PRIMARY HEALTH CARE RESEARCH DATABASE USING A COMBINATION OF SPIROMETRY MEASURES, SYMPTOMS, DRUG USE, AND FREE TEXT REVIEW.

    Oct 1, 2018, 00:00

  • PIN34 - COMPARING THE ESTIMATED PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PHID-CV AND PCV-13 IN THE ROUTINE IMMUNISATION PROGRAMME IN GAVI-ELIGIBLE COUNTRIES (SUB-SAHARAN AFRICA AND ASIA/OCEANIA)- A MODELLING STUDY

    Oct 1, 2018, 00:00

  • PSY180 - UK HEALTH TECHNOLOGY ASSESSMENT OF ORPHAN DRUGS FOR RARE ONCOLOGY VERSUS RARE DISEASE- DOES ORPHAN DESIGNATION MAKE ANY DIFFERENCE IN HTA PROCESS?

    Oct 1, 2018, 00:00

  • PMD163 - HTA OF ARTIFICIAL URINARY SPHINCTER (AUS) FOR THE TREATMENT OF SEVERE MALE POST-PROSTATECTOMY INCONTINENCE IN ITALY

    Oct 1, 2018, 00:00

  • PMS29 - SECUKINUMAB VERSUS ADALIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS- A COST PER RESPONDER ANALYSIS AMONG 52 WEEKS FROM A TUNISIAN PERSPECTIVE.

    Oct 1, 2018, 00:00

  • PSY54 - BUDGET IMPACT ANALYSIS OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS IN TURKEY

    Oct 1, 2018, 00:00

  • PRM145 - A NEW GRAPHICAL REPRESENTATION OF PROBABILITY SENSITIVITY ANALYSIS RESULTS AS AN ALTERNATIVE FOR THE SCATTER-PLOT

    Oct 1, 2018, 00:00

  • PHP330 - REAL-WORLD DATA COLLECTION ON MEDICAL DEVICES IN THE ERA OF VALUE-BASED HEALTHCARE- A LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSS5 - VISION-RELATED QUALITY OF LIFE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL AFLIBERCEPT- THE AQUA STUDY

    Oct 1, 2018, 00:00

  • PIN126 - THE QUALITY OF LIFE (QOL) LOSS ASSOCIATED WITH INVASIVE MENNINGOCOCCAL B DISEASE (MENB) IN GERMANY

    Oct 1, 2018, 00:00

  • PCN259 - A REAL-WORLD DATA STUDY REGARDING HOSPITAL RESOURCES USE AND COSTS ASSOCIATED WITH MELANOMA CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PMD146 - HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH ASEPTIC LOOSENING AFTER PRIMARY TOTAL KNEE ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PUK20 - COST-UTILITY ANALYSIS OF EXTRACORPOREAL LITHOTRIPSY VERSUS URETERORENOSCOPY-HOLMIUM LASER FOR TREATMENT OF URINARY STONES 20 MM.

    Oct 1, 2018, 00:00

  • PMD115 - THE DIAGNOSTIC METHODS AND COST OF LUNG CANCER IN GREECE

    Oct 1, 2018, 00:00

  • PHP124 - INTRANSPARENT EXCEPTIONAL FUNDING IN FRANCE ENSURING CONTINUITY OF PATIENT ACCESS TO INNOVATIVE TREATMENT

    Oct 1, 2018, 00:00

  • PMU99 - PERCEPTIONS OF THE GREEK POPULATION CONCERNING MEDICINES – A DESCRIPTIVE ANALYSIS

    Oct 1, 2018, 00:00

  • PMU82 - SOCIOECONOMIC AND HEALTH-RELATED FACTORS ASSOCIATED WITH ADHERENCE TO CHRONIC MEDICATION IN GREECE

    Oct 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Treatments for Chemotherapy-Naive Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2018, 00:00

  • PRM115 - MODELING DECLINE IN COGNITION TO DECLINE IN FUNCTION IN ALZHEIMER’S DISEASE (AD)

    Oct 1, 2018, 00:00

  • PCN332 - REAL-WORLD USAGE OF BORTEZOMIB IN COMBINATION WITH THALIDOMIDE AND DEXAMETHASONE (VTD) AS FRONTLINE (FL) TREATMENT IN STEM CELL TRANSPLANT (SCT) ELIGIBLE MULTIPLE MYELOMA (MM) PATIENTS ACROSS EU5 COUNTRIES

    Oct 1, 2018, 00:00

  • Accuracy of Linking VR-12 and PROMIS Global Health Scores in Clinical Practice

    Oct 1, 2018, 00:00

  • PMD85 - INDIRECT COMPARISON AND COST-EFFECTIVENESS ANALYSIS OF MINIMALLY INVASIVE ENDOVENOUS CYANOACRYLATE GLUE OCCLUSION, SURGICAL AND OTHER TREATMENT OPTIONS IN CHRONIC VENOUS INSUFFICIENCY

    Oct 1, 2018, 00:00

  • PCV9 - VENOUS THROMBOEMBOLISM PROPHYLAXIS STRATEGIES FOR PEOPLE UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT- A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS TO INFORM NICE CLINICAL GUIDELINE RECOMMENDATION

    Oct 1, 2018, 00:00

  • PHP357 - MAKING SENSE FROM ANTI-SENSE- LESSONS IN TRANSLATING EXPEDITED REGULATORY APPROVAL INTO REIMBURSEMENT AND COMMERCIAL SUCCESS

    Oct 1, 2018, 00:00

  • PMD34 - BUDGET IMPACT ANALYSIS (BIA) OF EMPLOYING A FEMALE EXTERNAL CATHETER (FEC) TO ASSIST WITH URINE OUTPUT MANAGEMENT (UOM) IN THE HOSPITAL SETTING

    Oct 1, 2018, 00:00

  • PCP62 - MARKET ACCESS UNDER AGILE CIRCUMSTANCES

    Oct 1, 2018, 00:00

  • PSY187 - THE QUANTITY AND QUALITY OF EVIDENCE SUPPORTING EUROPEAN MARKETING AUTHORISATION OF ORPHAN DRUGS- COMPARISON OF RARE ONCOLOGY VERSUS RARE DISEASE

    Oct 1, 2018, 00:00

  • PHP117 - TRENDS OF PRESCRIPTION FOR OFF-LABEL DRUGS IN KOREAN PEDIATRIC PATIENTS USING CLAIMS DATA- WITH A FOCUS ON CLINICAL AREAS AND PRIMARY DISEASES

    Oct 1, 2018, 00:00

  • PIN130 - QUALITY OF LIFE OF ADULT PATIENTS UNDERWENT POLIOMYELITIS INFECTION DURING CHILDHOOD

    Oct 1, 2018, 00:00

  • PHP44 - EXPLORING THE KNOWLEDGE AND PERCEPTION OF GENERIC MEDICINE USE AMONG COMMUNITY PHARMACISTS IN SAUDI ARABIA

    Oct 1, 2018, 00:00

  • PCN180 - PHARMACOECONOMIC ASSESSMENT OF FULVESTRANT VERSUS DD (DOXORUBICIN, DOCETAXEL) THERAPY IN POSTMENOPAUSAL WOMEN WITH METASTATIC ER (+) HER2 (-) BREAST CANCER IN UKRAINE

    Oct 1, 2018, 00:00

  • PMS63 - COST-EFFECTIVENESS OF ACTONEL® 35 MG (RISEDRONATE) GASTRO-RESISTANT TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE

    Oct 1, 2018, 00:00

  • PCV116 - DISCONTINUATION AND HEALTH CARE RESOURCE UTILISATION IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH APIXABAN OR WARFARIN IN ENGLAND

    Oct 1, 2018, 00:00

  • PIN119 - THERAPEUTIC SEQUENCES FOR THE TREATMENT OF PEOPLE LIVING WITH HIV TYPE 1 IN PORTUGAL

    Oct 1, 2018, 00:00

  • DS4 - A MULTI-DATABASE, MULTINATIONAL VALIDATION STUDY OF CARDIOVASCULAR DEATH, VENOUS THROMBOEMBOLIC EVENTS AND GASTROINTESTINAL DISEASES IN THE EU-ADR ALLIANCE

    Oct 1, 2018, 00:00

  • PND41 - HEALTHCARE COSTS OF PATIENTS WITH SPINAL MUSCULAR ATROPHY

    Oct 1, 2018, 00:00

  • PMD22 - THE EFFECTIVENESS OF ELECTRONIC LARYNX FOR SPEECH REHABILITATION OF LARINGECTOMIZED PATIENTS- A REVIEW OF THE LITERATURE

    Oct 1, 2018, 00:00

  • PCP1 - COMPARISON OF THE GERMAN MIXED PRICE MODEL AND INDICATION-SPECIFIC PRICING FOR MULTI-INDICATION PRODUCTS IN ONCOLOGY

    Oct 1, 2018, 00:00

  • PHP232 - A COMPARISON OF COST-EFFECTIVENESS ASSESSMENTS BETWEEN NICE AND SMC TECHNOLOGY APPRAISALS

    Oct 1, 2018, 00:00

  • PCV35 - SECONDARY PREVENTION FOR CARDIOVASCULAR DISEASE- DEFINITION OF POPULATION AND EVALUATION OF OUTCOMES USING REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PRS6 - THE CLINICAL EFFECTIVENESS OF PROPHYLACTIC VERSUS SELECTIVE USE OF SURFACTANT IN PRETERM INFANTS- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2018, 00:00

  • PRS5 - IDENTIFICATION AND ESTIMATION OF THE PREVALENCE OF ACUTE SEVERE ASTHMA IN FRANCE USING THE EGB CLAIM DATABASE

    Oct 1, 2018, 00:00

  • PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT

    Oct 1, 2018, 00:00

  • PND35 - HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COST TRAJECTORIES IN FIVE YEARS FOLLOWING MS DIAGNOSIS- REGISTER-BASED PROSPECTIVE COHORT STUDIES IN SWEDEN

    Oct 1, 2018, 00:00

  • PMU31 - A REVIEW OF MANAGED ACCESS AGREEMENTS (MAAS) AND PATIENT ACCESS SCHEMES (PASS) IN ENGLAND

    Oct 1, 2018, 00:00

  • PRM133 - ESTIMATED COST SAVINGS FROM DOSE BANDING GUIDANCE- A CASE STUDY USING TREATMENTS FOR STAGE IV MELANOMA

    Oct 1, 2018, 00:00

  • PND144 - REPORTED QUALITY OF LIFE IN PEOPLE WITH MULTIPLE SCLEROSIS UNDER LONG TERM TREATMENT WITH FAMPRIDINE

    Oct 1, 2018, 00:00

  • PSY143 - EPIDEMIOLOGY AND TREATMENT OF MICROSCOPIC COLITIS – REAL WORLD EVIDENCE FROM THE CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PND33 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY

    Oct 1, 2018, 00:00

  • PDB104 - IMPACT OF DAPAGLIFLOZIN ON REDUCING ECONOMIC BURDEN OF DIABETES IN EGYPT

    Oct 1, 2018, 00:00

  • PHP145 - NUMBER OF PHARMACISTS IN EUROPEAN COUNTRIES BETWEEN 2000-2015

    Oct 1, 2018, 00:00

  • PCN223 - WHAT UNDERLIES THE OBSERVED HOSPITAL VOLUME-OUTCOME RELATIONSHIP?

    Oct 1, 2018, 00:00

  • PHP206 - TUMOUR-AGNOSTIC AGENTS- ARE THEY FIT FOR REIMBURSEMENT?

    Oct 1, 2018, 00:00

  • PCN379 - QUANTITATIVE COMPARISON OF THE INFLUENCE OF OPEN LABEL TRIAL DESIGN ON PATIENT REPORTED OUTCOME RESPONSES – A METASTATIC MELANOMA CASE STUDY.

    Oct 1, 2018, 00:00

  • PRM175 - EQ-5D-3L VS. EQ-5D-5L- A CROSS-SECTIONAL COMPARISON OF MEASUREMENT PROPERTIES AMONG TOTAL HIP AND KNEE REPLACEMENT PATIENTS

    Oct 1, 2018, 00:00

  • AD4 - ARE PATIENT-REPORTED PERSISTENCE AND ADHERENCE TO TREATMENT FOR A CHRONIC DISEASE VALID OUTCOMES? AN EXAMPLE WITH OSTEOPOROSIS

    Oct 1, 2018, 00:00

  • PHP105 - A POPULATION-BASED DATA ANALYSIS OF DRUG PRESCRIPTION AND PATTERNS OF USE OF ANTIBIOTIC IN SOUTHERN ITALY POPULATION

    Oct 1, 2018, 00:00

  • PCP42 - ECONOMIC EVALUATION OF INTELLIGENT ROLLATORS – ESTIMATING THEIR BENEFITS

    Oct 1, 2018, 00:00

  • PCV68 - POTENTIAL SAVINGS IN HIGHEST PRESCRIBING REGIONS FOR DIRECT-ACTING ORAL ANTICOAGULANTS IN ENGLAND

    Oct 1, 2018, 00:00

  • QL1 - VALIDATION OF PROMIS PREFERENCE SCORE (PROPR) IN GERMAN PATIENTS WITH RHEUMATOLOGICAL CONDITIONS

    Oct 1, 2018, 00:00

  • PHP135 - CHANGES IN THE NUMBER OF DENTISTS IN EUROPEAN COUNTRIES BETWEEN 2000-2015

    Oct 1, 2018, 00:00

  • PCN353 - CONSTRUCT VALIDITY OF EQ-5D-3L IN NON-MELANOMA SKIN CANCER (NMSC)

    Oct 1, 2018, 00:00

  • PHP81 - COMPARISON OF SELECTED DRUGS PRICES IN EU COUNTRIES

    Oct 1, 2018, 00:00

  • PCV107 - MULTI-CRITERIA DECISION ANALYSIS (MCDA) - DISCUSSION ABOUT THE INCORPORATION OF RIOCIGUAT IN THE TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM (SUS)

    Oct 1, 2018, 00:00

  • PCN226 - BIOSIMILARS AND THE REGULATION OF ONCOLOGICAL PREPARATIONS IN GERMANY

    Oct 1, 2018, 00:00

  • PSY62 - DIRECT COST OFFSETS RELATED TO BELIMUMAB SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SPAIN

    Oct 1, 2018, 00:00

  • PCN368 - CONCORDANCE BETWEEN PATIENTS AND CLINICIANS’ REPORTING OF SYMPTOMATIC ADVERSE EVENTS IN CANCER CLINICAL TRIALS- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PRS49 - COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM + OLODATEROL VERSUS TIOTROPIUM BASED ON THE DYNAGITO TRIAL RESULTS IN FRANCE

    Oct 1, 2018, 00:00

  • PSY114 - COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH CONVENTIONAL THERAPY IN PATIENTS WITH CROHN’S DISEASE IN THE UNITED KINGDOM (UK)

    Oct 1, 2018, 00:00

  • PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A INJECTIONS

    Oct 1, 2018, 00:00

  • PCN74 - A BUDGET-IMPACT ANALYSIS OF ADJUVANT PERTUZUMAB AND TRASTUZUMAB IN EARLY HER2-POSITIVE BREAST CANCER

    Oct 1, 2018, 00:00

  • PCP70 - REGENERATIVE MEDICINE- A PROPOSED CLASSIFICATION FOR HEOR BASED ON THERAPEUTIC STRATEGY AND TECHNOLOGY TYPE

    Oct 1, 2018, 00:00

  • PMD81 - COST EFFECTIVENESS ANALYSIS OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND FOR REFRACTORY PAINFUL BONE METASTASES

    Oct 1, 2018, 00:00

  • PHP237 - OVERVIEW OF GERMAN AMNOG DOSSIERS WITH PRICE ANALYSIS BEFORE AND AFTER EARLY BENEFIT ASSESSMENT

    Oct 1, 2018, 00:00

  • PCN261 - A REAL-WORLD DATA STUDY REGARDING HOSPITAL RESOURCES USE AND COSTS ASSOCIATED WITH COLORECTAL CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PIN97 - VALIDATING DATA ON HEPATITIS C TESTING IN THE UK IN THE PRIMARY CARE SETTING

    Oct 1, 2018, 00:00

  • PSS36 - PHARMACOECONOMIC EVALUATION OF PHARMACOLOGICAL TREATMENT OPTIONS FOR PATIENTS WITH MODERATELY-SEVERE AND SEVERE PSORIASIS WITH BASE THERAPY RESISTANCE

    Oct 1, 2018, 00:00

  • PRM217 - THE ONLINE VERSION OF EMPRO- A NEW PLATFORM SYSTEM FOR THE STANDARDIZED APPRAISAL OF PRO INSTRUMENTS.

    Oct 1, 2018, 00:00

  • CP1 - MULTI-INDICATION THERAPIES- DEVELOPING A VALUE-BASED FRAMEWORK TO INCORPORATE OPPORTUNITY COST

    Oct 1, 2018, 00:00

  • PDB111 - TREND AND FACTORS ASSOCIATED WITH PREVENTABLE HOSPITALIZATION AMONG DIABETES MELLITUS PATIENTS IN A NATIONAL HEALTH INSURANCE PROGRAM

    Oct 1, 2018, 00:00

  • PIN90 - RECENT TRENDS IN MENINGOCOCCAL DISEASE-RELATED INPATIENT CARE IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PMH11 - E-THERAPIES IN PREVENTING AND TREATING EATING DISORDERS- REVIEW OF TRIALS AND REAL-WORLD EVIDENCE

    Oct 1, 2018, 00:00

  • PMH2 - EXAMINING PARKINSON’S DISEASE PSYCHOSIS TREATMENT OUTCOMES IN THE REAL WORLD- THE INSYTE OBSERVATIONAL STUDY – INITIAL YEAR 1 INTERIM FINDINGS

    Oct 1, 2018, 00:00

  • PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7

    Oct 1, 2018, 00:00

  • PUK28 - ASSESSMENT OF CHALLENGES ASSOCIATED WITH DRUG INNOVATION IN ORPHAN RENAL DISEASE

    Oct 1, 2018, 00:00

  • PCN227 - ACCESS TO ESSENTIAL ANTINEOPLASTICS AND IMMUNOSUPPRESSIVES

    Oct 1, 2018, 00:00

  • PRM80 - THE USE OF EXTERNAL DATA TO BETTER INFORM SURVIVAL EXTRAPOLATIONS IN SUBMISSIONS TO THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)

    Oct 1, 2018, 00:00

  • PUK3 - STUDY OF DIABETIC NEPHROPATHY PREVALENCE AMONG TYPE 2 DIABETIC OUTPATIENTS WITH UNCONTROLLED GLYCEMIA

    Oct 1, 2018, 00:00

  • PSY97 - COST-EFFECTIVENESS ANALYSIS OF ENZYME REPLACEMENT THERAPY FOR TYPE 1 GAUCHER DISEASE

    Oct 1, 2018, 00:00

  • PUK36 - COMPARISON OF PATIENT-REPORTED OUTCOMES IN RANDOMIZED CONTROLLED TRIALS AND IN OBSERVATIONAL STUDIES FOR OVERACTIVE BLADDER- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSY29 - REAL-WORLD DISCONTINUATION OF BIOLOGICAL TREATMENTS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS OVER THE FIRST 5 YEARS OF TREATMENT – A LITERATURE REVIEW OF DRUG SURVIVAL

    Oct 1, 2018, 00:00

  • PRM129 - DECISION ANALYTIC MODELS TO INFORM ABOUT THE OPTIMAL MAMMOGRAPHY SCREENING INTERVALS- A SYSTEMATIC REVIEW.

    Oct 1, 2018, 00:00

  • PMH23 - REAL-WORLD COSTS AND BUDGET IMPACT OF LONG-ACTING INJECTION ATYPICAL ANTIPSYCHOTICS FOR THE MANAGEMENT OF SCHIZOPHRENIA IN FRANCE

    Oct 1, 2018, 00:00

  • PCV92 - EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUE-ENGINEERED HEART VALVES IN THE AORTIC POSITION IN ELDERLY PATIENTS

    Oct 1, 2018, 00:00

  • PMD110 - COST-EFFECTIVENESS OF IMMUNOADSORPTION FOR INCOMPATIBLE KIDNEY TRANSPLANTATION IN GERMANY

    Oct 1, 2018, 00:00

  • PMH20 - BUDGETARY IMPACT OF TREATING OPIOID ADDICTION IN THE DANISH MUNICIPAL SETTING

    Oct 1, 2018, 00:00

  • PMU9 - PALLIATIVE CARE IN GERMANY- AN EPIDEMIOLOGICAL STUDY BASED ON REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PMS14 - CHILDHOOD OBESITY AND FRACTURE RISK- A REGION-WIDE LONGITUDINAL COHORT STUDY OF 466,000 CHILDREN AND UP TO 11 YEARS OF FOLLOW-UP

    Oct 1, 2018, 00:00

  • PDB15 - CARDIOVASCULAR SAFETY OF EMPAGLIFLOZIN VERSUS DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS- SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISONS

    Oct 1, 2018, 00:00

  • PMU1 - FREQUENCY OF REPORTABLE ADVERSE EVENTS IN HEALTH-RELATED SOCIAL MEDIA POSTS

    Oct 1, 2018, 00:00

  • PMH71 - AN ASSESSMENT OF HEALTH OUTCOMES BY PATIENT ACTIVATION LEVEL IN THE EU5

    Oct 1, 2018, 00:00

  • PRM170 - UTILIZING PATIENT COLLAGES IN QUALITATIVE INTERVIEWS TO FACILITATE DATA COLLECTION IN PATIENTS DIAGNOSED WITH ULCERATIVE COLITIS

    Oct 1, 2018, 00:00

  • PCP46 - A SIMPLE DECISION TREE TO IDENTIFY POTENTIAL APPLICATIONS OF MACHINE LEARNING AS AN ADDITION TO TRADITIONAL STATISTICAL ANALYSIS IN HEALTH ECONOMICS AND OUTCOMES RESEARCH

    Oct 1, 2018, 00:00

  • PRM255 - QUANTIFYING SYSTEMATIC ERROR IN UNANCHORED INDIRECT COMPARISONS- THE IN-SAMPLE METHOD

    Oct 1, 2018, 00:00

  • PSY179 - IMPACT ANALYSIS OF THE PHARMACEUTICAL COVERAGE EXPANDING POLICY FOCUSED ON ANTICANCER RARE DISEASE IN KOREA

    Oct 1, 2018, 00:00

  • PHP273 - A REVIEW OF ISSUES AFFECTING THE EFFICIENCY OF DECISION MAKING IN THE NICE SINGLE TECHNOLOGY APPRAISAL PROCESS

    Oct 1, 2018, 00:00

  • PMS119 - ACCEPTABILITY OF HEALTH PROBLEMS IN CHRONIC MUSCULOSKELETAL DISEASES

    Oct 1, 2018, 00:00

  • PSY213 - WHAT MATTERS TO INDIVIDUALS WITH SICKLE CELL DISEASE? PATIENT INPUT ON THE RELEVANT AND IMPORTANT SYMPTOMS AND IMPACTS OF THE CONDITION

    Oct 1, 2018, 00:00

  • PMS79 - PHYSIOTHERAPY UTILIZATION INDICES IN HOME CARE IN HUNGARY

    Oct 1, 2018, 00:00

  • PCN217 - KEEPING UP WITH THE COMPARATORS- TRENDS IN TARGETED CANCER THERAPIES BECOMING RIGHT COMPARATORS FOR PAYERS

    Oct 1, 2018, 00:00

  • PRM165 - INFLUENCE OF THE TIME HORIZON LENGTH ON THE RESULTS OF PHARMACOECONOMIC RESEARCH

    Oct 1, 2018, 00:00

  • PCV23 - TIME TO TREATMENT INTENSIFICATION IN NEW STATIN USERS

    Oct 1, 2018, 00:00

  • PRM37 - REPRODUCIBLE COST ANALYSIS MODELING AMONG DIFFERENT GEOGRAPHIC REGIONS- A CASE EXAMPLE OF DUAL-MOBILITY CUPS IN REVISION TOTAL HIP ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PHP240 - HEALTH TECHNOLOGY ASSESSMENTS OF BEVACIZUMAB BIOSIMILARS- COULD A DEMONSTRATION OF COST-EFFECTIVENESS CHANGE THE RECOMMENDATION FOR REIMBURSEMENT VERSUS THE ORIGINATOR?

    Oct 1, 2018, 00:00

  • PMS18 - BUDGET IMPACT ANALYSIS OF KNEE OSTEOARTHRITIS VISCOSUPPLEMENTATION TREATMENT IN BRAZIL

    Oct 1, 2018, 00:00

  • PUK10 - ANALYZING HEALTH-ECONOMIC EFFECTS OF A RENAL PRE-TRANSPLANT PATIENT-STRATIFICATION TOOL AT AN EARLY STAGE OF PRODUCT DEVELOPMENT

    Oct 1, 2018, 00:00

  • PMH68 - TREATMENT DISRUPTION AMONG PATIENTS WITH PARKINSON’S DISEASE WITH PSYCHOSIS ENROLLED IN US CENTERS FOR MEDICARE SERVICES

    Oct 1, 2018, 00:00

  • PMU45 - ESTIMATING THE CLINICAL AND ECONOMIC BURDEN OF HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE OR HEART FAILURE

    Oct 1, 2018, 00:00

  • PRS41 - COST-EFFECTIVENESS OF PIRFENIDONE FOR THE TREATMENT OF PATIENTS WITH MILD TO MODERATE IDIOPATHIC PULMONARY FIBROSIS IN GREECE

    Oct 1, 2018, 00:00

  • PRM5 - PROFILING OF DISEASE SYMPTOMS AND ADVERSE EVENTS- DOES SOCIAL MEDIA AUGMENT TRADITIONAL APPROACHES?

    Oct 1, 2018, 00:00

  • PRS53 - COST-UTILITY ANALYSIS OF SQ® HDM SLIT-TABLET IN PATIENTS WITH HOUSE DUST MITE ALLERGIC RHINITIS WITH OR WITHOUT ALLERGIC ASTHMA IN POLAND

    Oct 1, 2018, 00:00

  • PCN53 - STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS

    Oct 1, 2018, 00:00

  • PMS50 - COST-EFFECTIVENESS ANALYSIS OF APREMILAST IN THE TREATMENT OF PSORIATIC ARTHRITIS (PSA) IN THE SLOVAK REPUBLIC AND SLOVENIA

    Oct 1, 2018, 00:00

  • PIH12 - PHARMACOEPIDEMIOLOGY OF DRUGS IN PREGNANT WOMEN WITH EXTRAGENITAL PATHOLOGY

    Oct 1, 2018, 00:00

  • PHP214 - SHOULD DRUG PRICES DIFFER BY INDICATION? OUTLINING THE DEBATE ON INDICATION-BASED PRICING AND HOW IT HAS BEEN IMPLEMENTED

    Oct 1, 2018, 00:00

  • PRM47 - UNDERSTANDING KEY VALUE DRIVERS OF A NOVEL TREATMENT IN MANAGEMENT OF FAMILIAL CHYLOMICRONEMIA SYNDROME

    Oct 1, 2018, 00:00

  • PMS100 - COMPARISON OF LOW AND HIGH TOP BASKETBALL SHOES WITH RESERVE PLAYERS

    Oct 1, 2018, 00:00

  • PRM41 - ESTIMATION OF HOSPITAL COST SAVINGS ASSOCIATED WITH HYPOTENSION REDUCTION IN SEPTIC INTENSIVE CARE UNIT PATIENTS IN FRANCE

    Oct 1, 2018, 00:00

  • PMD59 - DEVELOPING A COMPREHENSIVE TREATMENT COST COMPARISON MODEL IN SICKLE CELL DISEASE

    Oct 1, 2018, 00:00

  • PCN204 - A SYSTEMATIC REVIEW OF BARRIERS AND FACILITATORS TO PARTICIPATION IN SHARED DECISION MAKING IN CANCER CARE- AN INTERNATIONAL PERSPECTIVE

    Oct 1, 2018, 00:00

  • PUK16 - COST-EFFECTIVENESS OF TOLVAPTAN IN CANADIAN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE- AN ADAPTATION OF THE ADPKD OUTCOMES MODEL

    Oct 1, 2018, 00:00

  • PRM117 - MULTI-COMPARATOR ICERS IN COST-EFFECTIVENESS ANALYSIS TO ACCOUNT FOR CHANGES IN CLINICAL PRACTICE AFTER THE INTRODUCTION OF A NEW TECHNOLOGY

    Oct 1, 2018, 00:00

  • PHP329 - THE REGISTRY EVALUATION AND QUALITY STANDARDS TOOL (REQUEST) FOR HEALTH TECHNOLOGY ASSESSMENT FROM AN OUTCOMES ASSESSMENT PERSPECTIVE

    Oct 1, 2018, 00:00

  • PIN127 - HETEROGENEOUS PREFERENCES FOR HIV/AIDS COUNSELING AND TESTING AMONG TWO HIGH RISK POPULATIONS IN NORTHERN TANZANIA - RESULTS FROM A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2018, 00:00

  • PMS60 - CLINICAL AND ECONOMIC "REAL WORLD” ANALYSIS OF THE SWITCHING FROM REMICADE (INFLIXIMABE) BY REMSIMA (INFLIXIMAB BIOSSIMILAR) OF PLANSERV PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS.

    Oct 1, 2018, 00:00

  • PRS94 - THE PARENTAL BURDEN OF CARING FOR A CHILD WITH PEANUT ALLERGY IN THE UK

    Oct 1, 2018, 00:00

  • PSS21 - HEALTH INSURANCE TREATMENT COST OF LICHEN PLANUS IN HUNGARY- COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PCN198 - AN ECONOMIC SYSTEMATIC LITERATURE REVIEW (SLR) FOR ANAPLASTIC LYMPHOMA KINASE-POSITIVE (ALK+) NON-SMALL-CELL LUNG CANCER (NSCLC)

    Oct 1, 2018, 00:00

  • PRM264 - DOES THE DESIGN OF A DISCRETE CHOICE ANALYSIS INFLUENCE ITS RESULTS? AN EXAMPLE STUDY OF WOMEN'S PREFERENCES FOR CONTRACEPTIVE PRODUCTS

    Oct 1, 2018, 00:00

  • PND1 - REVIEW OF THE LISTED SIDE EFFECTS OF MYASTHENIA GRAVIS TREATMENTS VERSUS THOSE RECORDED IN PUBLICATIONS

    Oct 1, 2018, 00:00

  • PIN115 - BARRIERS TO ACCESS AND IMPLEMENTATION OF ROTAVIRUS VACCINATION IN EUROPE

    Oct 1, 2018, 00:00

  • PHP181 - HEALTH TECHNOLOGY ASSESSMENT OF ONCOLOGY THERAPIES IN SPAIN AND ITALY- KEY METRICS AND CONSIDERATIONS

    Oct 1, 2018, 00:00

  • PCN287 - ANALYSIS OF IMPACTS OF THE SUPPLEMENTARY SCHEMES ON THE DRUG REIMBURSEMENT DECESION-MAKING UNDER THE POSITIVE LIST SYSTEM IN KOREA

    Oct 1, 2018, 00:00

  • PCN385 - QUALITY OF LIFE OF PATIENTS LIVING WITH METASTATIC COLORECTAL CANCER (MCRC)- EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) QUESTIONNAIRE RESULTS FROM A REAL WORLD EUROPEAN SURVEY

    Oct 1, 2018, 00:00

  • PHP322 - REAL-WORLD DATA - WHAT ARE THE USE AND REQUIREMENTS IN HEALTH-ECONOMIC APPRAISALS IN REINSCRIPTION BY THE FRENCH HAUTE AUTORITE DE SANTE (HAS)?

    Oct 1, 2018, 00:00

  • PHP277 - HOW DO BELLWETHER HTA AGENCIES EVALUATE BIOSIMILARS?

    Oct 1, 2018, 00:00

  • PDB135 - THE BURDEN OF DIABETES MELLITUS IN TAIWAN BASED ON PATIENT-REPORTED OUTCOMES

    Oct 1, 2018, 00:00

  • PMU22 - ANTICHOLINERGIC BURDEN IN OLDER PATIENTS- PHARMACIST INTERVENTION

    Oct 1, 2018, 00:00

  • PCN248 - USE OF CANCER DRUGS IN THE END-OF-LIFE IN MEN DYING OF CASTRATION-RESISTANT PROSTATE CANCER- POPULATION-BASED STUDY

    Oct 1, 2018, 00:00

  • PMS54 - COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT AS FIRST LINE OF TREATMENT IN COLOMBIAN PATIENTS WITH PSORIATIC ARTHRITIS

    Oct 1, 2018, 00:00

  • DS1 - EPIDEMIOLOGY, TREATMENT, AND HEALTH RESOURCE USE OF GOUT PATIENTS IN GERMANY- RESULTS FROM ANALYSIS OF A CLAIMS DATABASE

    Oct 1, 2018, 00:00

  • PIN25 - PROJECTED BURDEN OF VACCINE-PREVENTABLE DISEASES IN OLDER ADULTS IN THE UNITED STATES- IMPACT OF POPULATION AGING

    Oct 1, 2018, 00:00

  • PGI11 - HIGH LEVELS OF REIMBURSED COST AND USE OF GASTROENTEROLOGICAL DRUGS IN FRANCE

    Oct 1, 2018, 00:00

  • PSY184 - HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS- WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?

    Oct 1, 2018, 00:00

  • PND92 - ACCESS AND REIMBURSEMENT FOR CURRENT AND EMERGING ALZHEIMER’S DISEASE-MODIFYING THERAPIES IN THE EU5

    Oct 1, 2018, 00:00

  • PND120 - TREATMENT DECISIONS ABOUT FIRST-LINE DISEASE-MODIFYING TREATMENTS (DMTS) IN RELAPSING REMITTING MULTIPLE SCLEROSIS- A SYSTEMATIC REVIEW OF PATIENT NEEDS AND PREFERENCES

    Oct 1, 2018, 00:00

  • PHP85 - THE RISE OF THE NON-SUBMISSION – A WORRYING TREND FOR UK PATIENT ACCESS WITH ‘BREXIT’ APPROACHING

    Oct 1, 2018, 00:00

  • Editorial Board

    Sep 20, 2018, 13:52

  • An Economic Evaluation of Migalastat Versus ERT for the Treatment of Fabry Disease in Japan

    Sep 1, 2018, 00:00

  • The Closure of Taiwan’s Small Hospitals and Changes in Patterns of Inpatient Care, From 2003 to 2012

    Sep 1, 2018, 00:00

  • The Identification of Patient-Centric Value Drivers for Self-Paid Treatments in Asia

    Sep 1, 2018, 00:00

  • Accessibility and Equity of Current General Practitioner Distribution in China

    Sep 1, 2018, 00:00

  • The Impact of Risk-Sharing Agreements on Drug Reimbursement Decisions in South Korea

    Sep 1, 2018, 00:00

  • How Much do Malaysians Value Dengue Vaccine? Evaluating the Willingness to Pay (WTP) for Hypothetical Dengue Vaccine with Two-Part Model (TPM)

    Sep 1, 2018, 00:00

  • Systematic Literature Review of Cost-Effectiveness Evaluations in Japan

    Sep 1, 2018, 00:00

  • Cross Cultural Study to Predict Academic Achievement of Malaysian and Thailand Pharmacy Students 2017

    Sep 1, 2018, 00:00

  • Perceptions of Self-Medication Practices And Awareness Regarding Its Complications- A Community –Based Study

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Problems- Treatment Cost of Dislocation and Sprain of Joints And Ligaments of Knee

    Sep 1, 2018, 00:00

  • Current Situation, Causes, and Solutions to Drug Shortage in China—A Case Study of Jiangsu Province

    Sep 1, 2018, 00:00

  • Assessment of Knowledge, Perception and Attitude of Antibiotics use and Resistance Among the Medical and Paramedical Undergraduate Students of Gandaki Medical College Nepal

    Sep 1, 2018, 00:00

  • The Impact of Quality of Life on Costs of Chronic Kidney Disease in China’s Four Metropolises

    Sep 1, 2018, 00:00

  • Value-Based Healthcare Delivery - A Success Story for Taiwan ?

    Sep 1, 2018, 00:00

  • Hta Outcomes for Orphan Drugs in Oncology- Comparison of France, Germany and England

    Sep 1, 2018, 00:00

  • Incidence of Hip Fratures and Post Fracture Treatment In Women With Postmenopausal Osteoporosis In Taiwan

    Sep 1, 2018, 00:00

  • Trends in Health Information Technology Use Among Older People in The United States, 2009-2016

    Sep 1, 2018, 00:00

  • Dynamic Evaluation of Utilization of Innovative Oncology Drugs Under National Health Insurance System in Taiwan

    Sep 1, 2018, 00:00

  • The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China

    Sep 1, 2018, 00:00

  • An Overview of Systematic Reviews- Complementary Therapies for Cancer Patients

    Sep 1, 2018, 00:00

  • Inconsistency in Effectiveness Results in Pharmacoeconomic Models for Schizophrenia

    Sep 1, 2018, 00:00

  • Impact of Amnog on the Comparison of Orphan Drug Prices Between France and Germany

    Sep 1, 2018, 00:00

  • The Prevalence and Burden of Hypertension and Obesity Among Patients with Type 2 Diabetes in Urban China

    Sep 1, 2018, 00:00

  • Direct-to-Patient Contact- A Cost Effective Study Design Alternative for South East Asian and Rare-Disease Affiliate Groups Interested in Generating Local Real-World-Evidence Health Outcomes Data

    Sep 1, 2018, 00:00

  • A Cost Claims Database Study with Propensity Score Applications in Covariates Selection and Balancing

    Sep 1, 2018, 00:00

  • Cost Effectiveness of a Novel Pre-Operative Skin Prep. Vs. Conventional Practi An Analysis to Aid Hospital Based Clinical Decision Making in India

    Sep 1, 2018, 00:00

  • Burden and Source Of Out-Of-Pocket Health Expenditures in India

    Sep 1, 2018, 00:00

  • How Does G-BA Decision Impact Oncology Drug Prices in Germany?

    Sep 1, 2018, 00:00

  • Factors of High Asthma Expenditure in China- An 1-Year Retrospective Study

    Sep 1, 2018, 00:00

  • Medical Costs of Hypoglycemia in Type 1 and Type 2 Diabetes Patients Using Basal Insulin Analogues in China- Based on Medical Record Data

    Sep 1, 2018, 00:00

  • Healthcare Resource Utilization and Economic Burden of Herpes Zoster in Japanese Patients with Immunocompromised Conditions- A Claims Database Cohort Study

    Sep 1, 2018, 00:00

  • Assessing Health-Related Quality of Life In Patients With Osteoporotic Vertebral Fractures- A Systematic and Standardized Comparison of Available Instruments Using The Empro Tool

    Sep 1, 2018, 00:00

  • Patient Preference Study on Treatments of Non Small Cell Lung Cancer in Western China

    Sep 1, 2018, 00:00

  • Incorporating Adherence in Cost-Effectiveness Analyses of Interventions for Asthma Treatment- A Systematic Review

    Sep 1, 2018, 00:00

  • Health States Utility Values In Osteoporosis Using Time Trade-Off

    Sep 1, 2018, 00:00

  • A Locally Developed Quality of Life Measurement Scale for Family Caregivers of Patients with Advanced Cancers in Singapore

    Sep 1, 2018, 00:00

  • Adherence To Insulin In Singaporean Pediatric Type 1 Diabetes Patients And Its Association With Glycemic Control And Healthcare Utilization

    Sep 1, 2018, 00:00

  • Cost-Minimisation Analysis of Subcutaneous vs Intravenous Rituximab for the Treatment of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in Singapore

    Sep 1, 2018, 00:00

  • Evaluating the Efficacy of Vaccinating Pigs Against Gonadotropin Releasing Factor (Gnrf) with Regards to Asian Consumers' Attitudes

    Sep 1, 2018, 00:00

  • Europe-China Comparison of Orphan Drugs Approvals

    Sep 1, 2018, 00:00

  • Smoking Trends in Japan From 2008-2017- Results From The National Health and Wellness Survey

    Sep 1, 2018, 00:00

  • Survival And Healthcare Utilization After Venous Thromboembolism In Taiwan, A Nationwide Study

    Sep 1, 2018, 00:00

  • Comparing the Long-Term Impact on Healthcare Resources and Costs Due to Single-Piece Acrylic Intraocular Lens (IOL) Implantation During Cataract Surgery- A Cost-Consequence Analysis From Italian Healthcare System Perspective

    Sep 1, 2018, 00:00

  • A Study on Factors Influencing Drug Prices Among National Public Hospitals in the Philippines

    Sep 1, 2018, 00:00

  • Medical Expenditure for Lung Cancer Per Clinical Visit in China- A 10-Year Multicenter Retrospective Survey (2002-2011)

    Sep 1, 2018, 00:00

  • The Impact of Pre-Authorization Policy in the use of Colistin Antibiotic at King Salman Military Hospital Saudi Arabia

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of A Randomized Controlled Trial to Reduce Fear of Cancer Recurrence

    Sep 1, 2018, 00:00

  • Comparision of Child-Nursing Accident Sick-Pay and Accident Sick-Pay for Employees and Members of Individual and Corporate Enterprises in Hungary Between 2001-2016

    Sep 1, 2018, 00:00

  • Cost Analysis of Antibiotic Use in a Vietnamese Hospital

    Sep 1, 2018, 00:00

  • Expert Consensus in the Development of A Pediatric Patient-Reported Outcome Measure for Korean Medicine Treatment- A Delphi Study

    Sep 1, 2018, 00:00

  • Healthcare Utilization of Patient with Breast Cancer Following Exposure to Telemedical Care

    Sep 1, 2018, 00:00

  • Methodological Quality of Drug Safety Systematic Reviews- A Cross-Sectional Study

    Sep 1, 2018, 00:00

  • Cross-National Comparison of Biosimilar Medicines - Market Penetration and Competition with Originators

    Sep 1, 2018, 00:00

  • Are Time Trade-Off Values of Worse-Than-Death Health States Valid?

    Sep 1, 2018, 00:00

  • Modelling the Potential Impact of Pneumococcal Conjugate Vaccination in Thailand

    Sep 1, 2018, 00:00

  • Do People With Crohn's Disease Value Health States Differently Based on Experience?

    Sep 1, 2018, 00:00

  • Development of An Economic Model to Assess the Cost-Effectiveness of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan

    Sep 1, 2018, 00:00

  • Value-Based Health Care in Asia- Outcomes From Taiwan's Pay-For-Performance Programs

    Sep 1, 2018, 00:00

  • Markov Model Calibration of Weibull Distributed Transition Probabilities Using Scientific Python Optimization Packages

    Sep 1, 2018, 00:00

  • Innovative Access Pathways for Digital Healthcare Solutions- Learnings From a European Analogue Analysis for Asian HTA Bodies

    Sep 1, 2018, 00:00

  • Age and Gender Differences in Self-Reported Physical, Functional, and Mental Health in Taiwan

    Sep 1, 2018, 00:00

  • Factors Associated with Effectiveness of Population-Based Colorectal Cancer Screening

    Sep 1, 2018, 00:00

  • Are Orphan Drug Prices Fair?

    Sep 1, 2018, 00:00

  • Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies- Challenges and Potential Solutions

    Sep 1, 2018, 00:00

  • Cost-Utility Analysis of Eox Drug Regimen Versus Dcf Drug Regimen for the Patients with Advanced Gastric Cancer in Shiraz in 2015

    Sep 1, 2018, 00:00

  • Cost Analysis of Anti-Cancer Therapy in Ten Cancers in Taiwan

    Sep 1, 2018, 00:00

  • Electronic Cigarettes and Intention To Smoke Cigarettes Among Adolescents in Taiwan

    Sep 1, 2018, 00:00

  • Association Between Different Initial Date of Anti-Osteoporosis Medications With Subsequent Fracture-Related Hospitalization and Mortality- A Real-World Data Analyses 2008-2013

    Sep 1, 2018, 00:00

  • A Pilot Study For Estimation Of Willingness-To-Pay Per Quality Adjusted Life Year (WTP PER QALY) as Cost Effectiveness Threshold in Indonesia

    Sep 1, 2018, 00:00

  • Treatment Communication Between Patients With Serious Mental Illness (Smi) and Providers

    Sep 1, 2018, 00:00

  • A Comparison of Patient Characteristics Between Glp-1 Ra and Insulin Initiators in China

    Sep 1, 2018, 00:00

  • Economic Burden of Haze-Related Respiratory Illnesses in Selangor, Malaysia

    Sep 1, 2018, 00:00

  • Orphan Drug Policy and Access Dynamics in Japan

    Sep 1, 2018, 00:00

  • How Useful are the Pharmacoeconomics Systematic Reviews for Decision Making on Anticancer Drugs? a Systematic Review of Methods, Gaps, and Quality

    Sep 1, 2018, 00:00

  • Coverage Gap For Prescription Drugs Among Children in The Us- Evidence From the National Health Interview Survey

    Sep 1, 2018, 00:00

  • Health Care Utilization and Treatment Costs of the Patients with Hepatitis C Virus Infection in Zhengzhou, China

    Sep 1, 2018, 00:00

  • Trends and Patterns of Antibiotic Consumption in China- Evidence From A 5 Year Surveillance in Shandong Province, 2012-2016

    Sep 1, 2018, 00:00

  • Disability Adjusted Life Years for Liver Cancer in China- Trend Analysis from 1990-2016 and Future Prediction

    Sep 1, 2018, 00:00

  • Analysis of Assisted Reproductive Technologies in Ukraine, Japan and Usa

    Sep 1, 2018, 00:00

  • The Effect of a Schizophrenia Pay-For-Performance Program on Patient Outcomes–Propensity Score Matching with Difference-In-Differences Design

    Sep 1, 2018, 00:00

  • Cost-Analysis of Posaconazole for Prophylaxis Against Fungal Infections in Patients with Hematological Malignancies in Qatar

    Sep 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Randomized Trials of Surgery and Minimally Invasive Techniques Versus Cyanoacrylate Embolization for Varicose Veins

    Sep 1, 2018, 00:00

  • Think Big (Biosimilar Inclusion Guide) for Our Children

    Sep 1, 2018, 00:00

  • Burden of Ischemic Heart Disease And Stroke And The Impact Of Modifiable Risk Factors In Taiwan

    Sep 1, 2018, 00:00

  • Financial Disclosure Statements

    Sep 1, 2018, 00:00

  • Systematic Review of Economic Evaluations and Decision Models on Brca1/2-Mutations Related Health Interventions

    Sep 1, 2018, 00:00

  • Value-Based Decisions for Off-Patent Pharmaceuticals in Developing Countries – A Pilot Study Using Multi-Criteria Decision Analysis for Tenders in Indonesia

    Sep 1, 2018, 00:00

  • European Experiences of Cross-Border Collaboration in Procurement of Health Technologies

    Sep 1, 2018, 00:00

  • Concept of Data Security and Outpatient Monitoring of General Health Status

    Sep 1, 2018, 00:00

  • Cost Per-Responder Analysis of Secukinumab Compared To Other Biologics For The Treatment of Psoriatic Arthritis In Saudi Arabia

    Sep 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infection in Japan

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Problems- Treatment Cost of Muscular Injuries At Ankle and Foot

    Sep 1, 2018, 00:00

  • Cost- Effectiveness of Deep Molecular Response with First- Line Nilotinib vs. Imatinib in PH+ Chronic Myeloid Leukaemia Measured by Effectively Treated Patient- Years in Bulgaria

    Sep 1, 2018, 00:00

  • Epidemiological Characteristics, Medical Cost and Healthcare Resource Utilization of Diabetes-Related Complications Among Chinese Patients with Type 2 Diabetes Mellitus

    Sep 1, 2018, 00:00

  • EQ-5D-5L Derived Population Norms for Health-Related Quality of Life for Hong Kong General Population

    Sep 1, 2018, 00:00

  • “I Know Some People”- The Impact Of Social Capital on Primary Health Care Utilization of Residents in China

    Sep 1, 2018, 00:00

  • Is The Oral Contraceptive Pill Rx to Otc Switch Cost-Effective?

    Sep 1, 2018, 00:00

  • Descriptive Analysis of Drug Expense for Anti-Vascular Endothelial Growth Factor Therapy in Taiwan

    Sep 1, 2018, 00:00

  • Determinants of Unmet Needs and Impact on Ambulatory Health Care Expenditures

    Sep 1, 2018, 00:00

  • Cost-Effectiveness Analysis of New Oral Anticoagulants Compared To Warfarin In Thai Patients With Non-Valvular Atrial Fibrillation

    Sep 1, 2018, 00:00

  • Using EORTC QLQ-BR53 to Assess Health-Related Quality of Life in Women Breast Cancers

    Sep 1, 2018, 00:00

  • Validation of Algorithms to Identify Acute Myocardial Infarction, Ischemic Stroke, and Hemorrhagic Stroke Cases from Japanese Claims Database

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Screening a 5 Year Old Child for Hearing Loss Using Sound Scouts Compared with no Screening- A Decision Model Analysis

    Sep 1, 2018, 00:00

  • Understanding the Evidence Needs and Willingness to Pay of European Stakeholders for Digital Health Interventions

    Sep 1, 2018, 00:00

  • Consumer Willingness-To-Pay and Preference for Skin Cancer Screening Services in Australia

    Sep 1, 2018, 00:00

  • Cost–Effectiveness of Remifentanil Versus Fentanyl in Adult Surgery Based on a Meta Analysis of Randomized Controlled Trials

    Sep 1, 2018, 00:00

  • Direct Medical Costs Associated with Opportunistic Infections in Hiv-Infected Patients in Taiwan

    Sep 1, 2018, 00:00

  • Health Utility Scores in Patients With Type 2 Diabetes Mellitus in Indonesia

    Sep 1, 2018, 00:00

  • The Effect of HIP Fat on Health- Based on the Correlation Analysis Between HIP Circumference and Quality of Life

    Sep 1, 2018, 00:00

  • Local Inputs for A Societal Perspective- Estimating the Friction Period in Australia

    Sep 1, 2018, 00:00

  • Evolution of Hta System in Japan- Progress and Conservatism

    Sep 1, 2018, 00:00

  • Trend of Cost of Newer Glucose-Lowering Agents in Patients with Type 2 Diabetes Mellitus- Evidence From a Medical System in Taiwan

    Sep 1, 2018, 00:00

  • Estimating Cost of Diabetes and its Complications in Indonesia, Vietnam and the Philippines using National Claims Databases

    Sep 1, 2018, 00:00

  • Economic Analysis of Urea-Excipient Drug-Coated Balloon Therapy for Treatment of Femoropopliteal Artery Disease in Japan

    Sep 1, 2018, 00:00

  • Cost Analysis of Changing A Model of Care and Employing General Practitioners within Residential Aged Care Facilities Based on A Prospective, Stepped-Wedge, Cluster Randomised Trial in an Australian Setting

    Sep 1, 2018, 00:00

  • Quality of Life of Various Hepatitis C Disease Stages in an Asian Middle Income Country- Data From Malaysia

    Sep 1, 2018, 00:00

  • An Investigation of Minor Ailments Management By Elderly in Non-Urban Areas

    Sep 1, 2018, 00:00

  • Effect of Pharmacist’s Intervention on the Cost of Clinical Pathway for Gastric Cancer Operation

    Sep 1, 2018, 00:00

  • Trends in Prevalence of Statin Use and Treatment Burden for Statin Users with Comorbidities in South Korea

    Sep 1, 2018, 00:00

  • An Exploration of Pharmacoeconomic Publication Trends in Japan, Singapore and China Between 2000–2018

    Sep 1, 2018, 00:00

  • Increased Length of Stay- Identification of Predictors in Patients With Diabetic Foot Surgery

    Sep 1, 2018, 00:00

  • Efficacy and Safety in Self-Prepared Nasal Saline Irrigation and Clinical Outcome in Patient With Allergic Rhinitis

    Sep 1, 2018, 00:00

  • A Cross Country Comparison of the Reimbursement Requirements in Endemic and Non-Endemic Settings- An Application to a Dengue Vaccine

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Problems- Treatment Cost of Dislocation and Sprain of Joints and Ligaments At Ankle

    Sep 1, 2018, 00:00

  • The Interactions Between Underlying Risk Factors And Climate Changes In The Occurrence Of Acute Myocardial Infarction – A Nationalwide Study

    Sep 1, 2018, 00:00

  • Factors Affecting the Convenience of Cancer Patients for Drug Clinical Trials in Turkey- Final Analysis of A Multicenter Study

    Sep 1, 2018, 00:00

  • Antidiabetic Drugs Prescription Spatial Variability

    Sep 1, 2018, 00:00

  • Evaluating Availability, Prices and Affordability- Case Study of Selected Oncology and Innovator Medicines in Malaysia

    Sep 1, 2018, 00:00

  • Comparison of Clinical Burden of Hcv Infection Between Asia and Europe- an Overview of Systematic Review

    Sep 1, 2018, 00:00

  • Humanistic and Economic Burden of HCV Infection- An Overview of Systematic Review

    Sep 1, 2018, 00:00

  • The Impact of Generic Drug Entry on Market Shares and Prices of Brand-Name Drugs– Evidence from Chinese Pharmaceutical Market

    Sep 1, 2018, 00:00

  • Pharmacoeconomics Education in Schools of Pharmacy in Japan- A Questionnaire Survey

    Sep 1, 2018, 00:00

  • The Place of Ehealth Interventions in the Management Pathway of Inflammatory Bowel Disease (Ibd) Patients- A Systematic Review

    Sep 1, 2018, 00:00

  • Direct Medical Costs Associated with Cardiovascular Diseases Among the HIV-Infected Patients in Taiwan- A Population-Based Study

    Sep 1, 2018, 00:00

  • Cost-Minimisation Analysis of Subcutaneous Versus Intravenous Trastuzumab for the Treatment of Early Breast Cancer and Metastatic Breast Cancer in Singapore

    Sep 1, 2018, 00:00

  • On the Value of the Umbilical Cord Blood Supply

    Sep 1, 2018, 00:00

  • Health Insurance Coverage and Statin Prescription Among Adults in The US

    Sep 1, 2018, 00:00

  • Economic Impact of Delayed Access to Sofosbuvir-Based Regimen Under the Thai Universal Health Coverage (UHC)

    Sep 1, 2018, 00:00

  • Value-Based Pricing in Singapore- Is it a Race to the Bottom?

    Sep 1, 2018, 00:00

  • CORRECTION

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Vedolizumab for the Management of Moderate-To-Severe Ulcerative Colitis in Thailand

    Sep 1, 2018, 00:00

  • Cost Minimization Study between Intravenous Rituximab (R-IV) vs Subcutaneous Rituximab (R-SC) in Thai Patients with Diffused Large B-CELL Lymphoma (DLBCL)- A Simulation of Electronic Health Record (E-HR) and Evidence Synthesis

    Sep 1, 2018, 00:00

  • The Impact of Glycemic Control on Cognition in People with Type 2 Diabetes

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Conditions- Treatment Cost of The Injuries of Lower Leg

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Durvalumab after Chemoradiation in Stage III Non-Small Cell Lung Cancer (Nsclc)

    Sep 1, 2018, 00:00

  • Identify The Temporal Medication Pattern In The Hypertensive Patients Using Sequential Pattern Mining and Relate The Patterns To The Outcome and Cost

    Sep 1, 2018, 00:00

  • Patient Involvement in Health Technology Assessments- An International Comparison

    Sep 1, 2018, 00:00

  • A Meta-Analysis of Randomized Controlled Trials Comparing Once-Weekly Semaglutide to Control Therapy for the Treatment of Type 2 Diabetes

    Sep 1, 2018, 00:00

  • Willingness to Pay Per Quality-Adjusted Life in Taiwan

    Sep 1, 2018, 00:00

  • The Effect of Alternative Therapy Interventions On The Quality of Life of Dementia Patients- Meta-Analyses

    Sep 1, 2018, 00:00

  • How Errors in the Implementation of Background Mortality Leads to Bias in Models

    Sep 1, 2018, 00:00

  • Quality-Adjusted Life-Years without Constant Proportionality

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease- An Australian Perspective

    Sep 1, 2018, 00:00

  • Cost Per-Responder Analysis of Secukinumab Compared to Other Biologics for Treatment of Moderate to Severe Psoriasis Patients in Saudi Arabia

    Sep 1, 2018, 00:00

  • The Health Economic Impact of Optimizing Post-Hospitalization Management For An Exacerbation in Copd Patients in China

    Sep 1, 2018, 00:00

  • The “Second Negotiation” Policy in Chinese Hospitals

    Sep 1, 2018, 00:00

  • Development and Validatin of A Practical Protocol For Improving The Quality Of Care of Patients Encounter Osteoporotic Fracture

    Sep 1, 2018, 00:00

  • Budget Impact of Orbital Atherectomy Compared to Rotational Atherectomy in Patients with Severely Calcified Coronary Artery Lesions in Japan

    Sep 1, 2018, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsule (Original) Compared With Immediate-Release Phenytoin Capsule (Generic) for Epilepsy Patients in Thailand

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Insulin Glargine/Lixisenatide Titratable Fixed-Ratio Combination for Patients with Basal Insulin-Treated Type 2 Diabetes in South Korea

    Sep 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of u sing an Innovative Gradually Reducing Femoral Radius Design Implant VS. A Class of Metal-Backed Implants for Patients Undergoing Total Knee Arthroplasty (TKA) Surgery from an Indian Societal Perspective

    Sep 1, 2018, 00:00

  • Pharmacist Involvement with Elderly Patients with Polypharmacy to Decrease Medical Service Use- Experience in Taiwan

    Sep 1, 2018, 00:00

  • An Analysis of Price and Access Timeline of Oncology Drugs Across Eu5 Countries

    Sep 1, 2018, 00:00

  • Common Errors Made in Analyzing Japanese Claims Databases and how to Avoid them

    Sep 1, 2018, 00:00

  • The Economic Burden of Sickle Cell Disease in the United States

    Sep 1, 2018, 00:00

  • Differences In ADL At Admission And Discharge For Stroke Patients

    Sep 1, 2018, 00:00

  • Economic Burden of Atrial Fibrillation in Japan

    Sep 1, 2018, 00:00

  • Efficacy and Safety of Eribulin Compared with Control Therapy in Patients with Locally Advanced or Metastatic Breast Cancer- A Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2018, 00:00

  • Grey Correlation Analysis on The Total Health Expenditure Structure and Per Capita Medical Expenses in China

    Sep 1, 2018, 00:00

  • Hospital Cost Savings Associated with Flowable Gelatin Hemostat for Anterior Cervical Spine Surgery in Chinese Patients- A Real-World Retrospective Cohort Study

    Sep 1, 2018, 00:00

  • Pharmacoeconomic Evaluation of Bariatric Surgery Program in Morbidly Obese Diabetes Mellitus Type Two Patients in Thailand

    Sep 1, 2018, 00:00

  • Utilization of Patient-Reported Outcomes in Asian Trial Literature

    Sep 1, 2018, 00:00

  • Economic Impact of Hypoglycemia Among Type 2 Diabetes Mellitus in Taiwan

    Sep 1, 2018, 00:00

  • From Per-Diem Payment to Case-Based Per-Episode Payment for Acute Mental Disorders in Guangzhou, China- A Propensity Score Matching and Difference-in-Differences Analysis Using Real World Data

    Sep 1, 2018, 00:00

  • Pricing and Reimbursement Frameworks in China, Japan and South Korea with Focus on Key Reimbursement Drivers

    Sep 1, 2018, 00:00

  • International Drug Price Comparison by Atc Groups

    Sep 1, 2018, 00:00

  • A Cost-Outcome Study- A Real-World Investigation of Long-Term Inpatient Hospital Utilisation and Costs for a Retrospective Cohort of Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia’s Activity Based Fund ...

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Down-Scheduling Triptans in Australia

    Sep 1, 2018, 00:00

  • The Comparative Analysis of Risk-Sharing Agreements in Korea, Australia, Taiwan Focusing on Operation

    Sep 1, 2018, 00:00

  • 180-Day Mortality and Its Predictors In Women With Contralateral Hip Fracture After Femoral Neck Fracture

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Immunotherapy Strategies for Advanced Melanoma in Taiwan

    Sep 1, 2018, 00:00

  • Cost-Effectiveness Of Internet-Delivered Cognitive Behaviour Therapy For Adolescents With Irritable Bowel Syndrome

    Sep 1, 2018, 00:00

  • Evaluation of the Efficacy of Acupuncture on Vascular Dementia After Stroke in Taiwan

    Sep 1, 2018, 00:00

  • A Novel, Simple and Accurate Method to Map Quality-Of-Life Scores to Utility Values

    Sep 1, 2018, 00:00

  • Stratification of Dengue Induced Acute Kidney Injury by Using Conventional, Akin and Rifle Definitions- A Comparative Analysis

    Sep 1, 2018, 00:00

  • Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan

    Sep 1, 2018, 00:00

  • Fluorodeoxyglucose Positron Emission Tomography with Computerised Tomography for Oncological Indications- A Pragmatic Approach to Guide Subsidy Decisions

    Sep 1, 2018, 00:00

  • Is the risk of developing depressive disorder following osteoarthritis and rheumatoid arthritis different?

    Sep 1, 2018, 00:00

  • Real World Health Insurance Cost of Femoral Neck Fracture In Hungary- A Nationwide Cost of Illness Study

    Sep 1, 2018, 00:00

  • Antibiotic use in a Clinical Department of a University Hospital in Vietnam

    Sep 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Same Day Surgery and Anesthesia in Thailand

    Sep 1, 2018, 00:00

  • Health Related Income Loss in India- Are Acute Health Conditions Expensive?

    Sep 1, 2018, 00:00

  • A Cost-Benefit Analysis of The Second Generation Cessation Services Payment Scheme in Taiwan From A Societal Viewpoint

    Sep 1, 2018, 00:00

  • Patient-Reported Outcome Measures for Medical Devices in Asia- A Literature Review

    Sep 1, 2018, 00:00

  • Treatment Patterns And Drug Adherence In Patients With Hypertension And Dyslipidemia- Korean HTN/DYS Outcomes Research Group

    Sep 1, 2018, 00:00

  • Uptake of Discrete Choice Experiments in Healthcare in Southeast Asia- A Systematic Review

    Sep 1, 2018, 00:00

  • Reporting Quality of Drug Safety Systematic Reviews- A Cross-Sectional Study

    Sep 1, 2018, 00:00

  • Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Relapse/Refractory Mantle Cell Leukemia (Rrmcl) Patients in China

    Sep 1, 2018, 00:00

  • The Impact of Pricing Policy on Short-Supplied Drugs in Shandong, China- Interrupted Time Series Study

    Sep 1, 2018, 00:00

  • Age- and Gender-Specific Disease Burden Under Taiwan's National Health Insurance System

    Sep 1, 2018, 00:00

  • Trends in Medication Utilization, Glycemic Control, Rates of Severe Hypoglycemia and Lower Limb Amputations Among Type 2 Diabetes Patients with Chronic Kidney Disease in Singapore from 2012 to 2017

    Sep 1, 2018, 00:00

  • Dabigatran vs. Warfarin for Treatment of Atrial Fibrillation

    Sep 1, 2018, 00:00

  • The Public Health Impact and Cost-Effectiveness of School-Based Nine-Valent Human Papillomavirus Female Vaccination Compared with BI-Valent and Quadrivalent Vaccination in Malaysia

    Sep 1, 2018, 00:00

  • The Direct Cost of Smoking Attributable Medical Expenditures in Taiwan

    Sep 1, 2018, 00:00

  • Direct Observation of Drug Counseling Activities in Community Pharmacies in Hue City, Vietnam

    Sep 1, 2018, 00:00

  • A Comparative Analysis of Key Trends of Pharmaceutical Market and Reimbursement in Ukraine and Poland

    Sep 1, 2018, 00:00

  • Health Insurance Cost Of Varicose Veins Of Lower Extremities In Hungary- A Real World Cost Of Illness Study

    Sep 1, 2018, 00:00

  • Cost Effectiveness Analysis of Using a Novel Diagnostic Test in Gastric Cancer Screening Programs for Population at Intermediate and High Risk

    Sep 1, 2018, 00:00

  • Development of a Prediction Model of Hemoglobin A1C Based On Statistical Machine Learning Using Clinical Data

    Sep 1, 2018, 00:00

  • Application of Constrained Optimization Methods in Health Services Research- Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force

    Sep 1, 2018, 00:00

  • 1 Year Health-Related Quality-Of-Life Outcomes after Percutaneous Coronary Intervention in Patients with End-Stage Renal Failure

    Sep 1, 2018, 00:00

  • Long-Term Efficacy Of Lower Intensity Statin Therapy In Chinese Acute Coronary Syndrome Patients

    Sep 1, 2018, 00:00

  • The Effect of Formal Education on the Nutrition-Related Knowledge Regarding Iron Deficiency Anemia in Anemic Women of A Developing Nation

    Sep 1, 2018, 00:00

  • Influence Of Self-Perceived Risk, Motivators And Barriers On Cardiovascular Health Among Young And Middle-Aged Adults In Hong Kong

    Sep 1, 2018, 00:00

  • Schizophrenia- Study of Epidemiological and Economic Regional Disparities

    Sep 1, 2018, 00:00

  • Impact of Pharmacists' Assistance in Care of Asthma Patients in A Tertiary Care Hospital

    Sep 1, 2018, 00:00

  • Changes in The Income of Health Care Professionals in Ambulatory Care in Hungary

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Statin Therapy For Secondary Prevention Among Patients With Coronary Artery Disease With Baseline LDL-C Level Of 70–100 Mg/DL In Taiwan

    Sep 1, 2018, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67 (current)
  • 68
  • 69
  • 70
  • »